February 2, 2021
Retrained generic antibodies can recognize SARS-CoV-2Hepatitis B antibody is a good choice for recognizing new virus
October 29, 2020
UIC opens phase 3 monoclonal antibody clinical trialResearchers now enrolling asymptomatic people who live with COVID-positive patients